Requires that whenever laboratory tests shall be required to be covered, such tests shall include testing for Lyme disease including at a minimum both the enzyme-linked immunosorbent assay and Western blot tests.
STATE OF NEW YORK
________________________________________________________________________
7753
IN SENATE
February 16, 2018
___________
Introduced by Sen. RITCHIE -- read twice and ordered printed, and when
printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to requiring that more
expansive Lyme disease testing be offered as part of most laboratory
tests covered by health insurance
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Subsection (i) of section 3216 of the insurance law is
2 amended by adding a new paragraph 34 to read as follows:
3 (34) For the purposes of this subsection, whenever laboratory tests
4 shall be required to be covered, such tests shall include testing for
5 Lyme disease. Coverage shall include at minimum both the enzyme-linked
6 immunosorbent assay (ELISA) and western blot tests, regardless of wheth-
7 er they were conducted consecutively or simultaneously. Coverage shall
8 not be contingent on such results of either test. Rather, coverage shall
9 be contingent only on such test having been administered pursuant to a
10 doctor's order.
11 § 2. This act shall take effect on the one hundred twentieth day after
12 it shall have become a law; provided however, that effective immediate-
13 ly, the addition, amendment, and/or repeal of any rule or regulation
14 necessary for the implementation of this act on its effective date are
15 authorized to be made and completed on or before such effective date.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD14212-01-8
